Clinical Research Directory
Browse clinical research sites, groups, and studies.
Evaluation of Serum Preptin Levels in Patients With Polycystic Ovary Syndrome
Sponsor: GÜLDEN ANATACA
Summary
Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age and is strongly associated with insulin resistance and metabolic dysfunction. Preptin is a pancreatic peptide co-secreted with insulin and has been implicated in glucose metabolism and insulin resistance. However, limited data exist regarding serum preptin levels in patients with PCOS. The aim of this study is to evaluate serum preptin levels in women diagnosed with PCOS and to investigate the relationship between preptin levels and insulin resistance parameters.
Official title: Evaluation of Serum Preptin Levels and Their Relationship With Insulin Resistance in Patients With Polycystic Ovary Syndrome
Key Details
Gender
FEMALE
Age Range
18 Years - 45 Years
Study Type
OBSERVATIONAL
Enrollment
60
Start Date
2026-07-30
Completion Date
2026-09-30
Last Updated
2026-07-30
Healthy Volunteers
No